SCHEMBL7444764

SCHEMBL7444764

CCCC[Sn](CCCC)(CCCC)CO[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17110456 0.80
SCHEMBL640225 0.79
SCHEMBL7645265 0.75 ADRB2 (0.32)
SCHEMBL4881159 0.74 TSHR (0.33)
SCHEMBL510037 0.72 TSHR (0.32)
SCHEMBL509694 0.70 LMNA (0.30)
SCHEMBL20607569 0.70 LMNA (0.30)
SCHEMBL29082891 0.70 TSHR (0.40)
SCHEMBL135552 0.69 TSHR (0.46)
SCHEMBL28438742 0.69 TSHR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403578-B1 ANTICOAGULANTS, CARDIOVASCULAR DISORDERS SMITHKLINE BEECHAM CORPORATION 2002-06-11 US disclosed
EP-0674623-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1995-10-04 EP disclosed
WO-1994014776-A2 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-07-07 WO disclosed